News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Appropriate Use of Growth Hormone Therapy in Adults: A Collaborative Approach to Deliver Effective P

Treatment of the Adult and Transitional Patient

ByGary Owens, MD,Donald Balfour, MD, FACP,S. Thomas Bigos, MD,Jay Cohen, MD, FACE,James Grua, MD, PhD, FACE,Wynter Kipgen, MD,Rajendra Ratnesar, MD,Kenneth L. Schaecher, MD,Mary Lee Vance, MD,a

October 1st 2004

Appropriate Use of Growth Hormone Therapy in Adults: A Collaborative Approach

ByDavid Cook, MD,Gary Owens, MD

October 1st 2004

Human Growth Hormone Treatment in Adults: Balancing Economics and Ethics

ByDavid Cook, MD,Gary Owens, MD,Michael Jacobs, RPh

October 1st 2004

Prescription Benefit Design: Perspectives, Reimbursement Issues, and Future Trends

ByGary Owens, MD,Donald Balfour, MD, FACP,Jay Cohen, MD, FACE,Sanford Cohen, MD,Michael Jacobs, RPh,Michael Lease, MS, PharmD, FASCP,Rajendra Ratnesar, MD,Kenneth L. Schaecher, MD,David E.

October 1st 2004

Clinical Presentation and Diagnosis: Growth Hormone Deficiency in Adults

ByGary Owens, MD,Donald Balfour, MD, FACP,Beverly MK Biller, MD,Jay Cohen, MD, FACE,Michael Jacobs, RPh,Michael Lease, MS, PharmD, FASCP,Rajendra Ratnesar, MD,Kenneth L. Schaecher, MD,David

October 1st 2004

Developing a Rational Approach for the Use of Growth Hormone in Nonpediatric Patients

ByDavid Cook, MD,Gary Owens, MD

October 1st 2004

Participating Faculty

By

October 1st 2004

CME/CE Quiz

By

October 1st 2004

Trending on AJMC

DOJ Abandons Olmstead Defense as Texas v Kennedy Advances

FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes

Myasthenia Gravis Linked to Greater Longevity Than Multiple Sclerosis

FDA Approves Rusfertide to Treat Erythrocytosis In Polycythemia Vera

Unvaccinated COVID-19 Infection Tied to Higher Myocarditis Risk